![Drew Moghanaki 🐕 on Twitter: "The Tammemagi PLCOm2012 6-year lung cancer risk calculator is now available as a FREE app. Co-developed with @findlungcancer. #lcsm #radonc https://t.co/OEU2H8Qgre https://t.co/4LMzphHhKe" / Twitter Drew Moghanaki 🐕 on Twitter: "The Tammemagi PLCOm2012 6-year lung cancer risk calculator is now available as a FREE app. Co-developed with @findlungcancer. #lcsm #radonc https://t.co/OEU2H8Qgre https://t.co/4LMzphHhKe" / Twitter](https://pbs.twimg.com/media/EwJwxX2VcAM7Q_s.jpg)
Drew Moghanaki 🐕 on Twitter: "The Tammemagi PLCOm2012 6-year lung cancer risk calculator is now available as a FREE app. Co-developed with @findlungcancer. #lcsm #radonc https://t.co/OEU2H8Qgre https://t.co/4LMzphHhKe" / Twitter
![ColoRectal Cancer Predicted Risk Online (CRC-PRO) Calculator Using Data from the Multi-Ethnic Cohort Study | American Board of Family Medicine ColoRectal Cancer Predicted Risk Online (CRC-PRO) Calculator Using Data from the Multi-Ethnic Cohort Study | American Board of Family Medicine](https://www.jabfm.org/content/jabfp/27/1/42/F1.large.jpg)
ColoRectal Cancer Predicted Risk Online (CRC-PRO) Calculator Using Data from the Multi-Ethnic Cohort Study | American Board of Family Medicine
![Calcitonin and Carcinoembryonic Antigen (CEA) Doubling Time Calculator | American Thyroid Association Calcitonin and Carcinoembryonic Antigen (CEA) Doubling Time Calculator | American Thyroid Association](https://www.thyroid.org/wp-content/uploads/2016/10/calculator-icon-blue-2.png)
Calcitonin and Carcinoembryonic Antigen (CEA) Doubling Time Calculator | American Thyroid Association
![A Validated Clinical Risk Prediction Model for Lung Cancer in Smokers of All Ages and Exposure Types: A HUNT Study - ScienceDirect A Validated Clinical Risk Prediction Model for Lung Cancer in Smokers of All Ages and Exposure Types: A HUNT Study - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2352396418301142-t1.jpg)
A Validated Clinical Risk Prediction Model for Lung Cancer in Smokers of All Ages and Exposure Types: A HUNT Study - ScienceDirect
![Simple online calculator helps women determine their risk of breast cancer | The Independent | The Independent Simple online calculator helps women determine their risk of breast cancer | The Independent | The Independent](https://static.independent.co.uk/s3fs-public/thumbnails/image/2015/10/01/22/cancercalculator.gif)
Simple online calculator helps women determine their risk of breast cancer | The Independent | The Independent
![Galen eCalcs - Calculator: Breast Cancer Risk - Galen Healthcare Solutions - Allscripts TouchWorks EHR Wiki Galen eCalcs - Calculator: Breast Cancer Risk - Galen Healthcare Solutions - Allscripts TouchWorks EHR Wiki](https://wiki.galenhealthcare.com/images/f/f0/CancerImage01.png)
Galen eCalcs - Calculator: Breast Cancer Risk - Galen Healthcare Solutions - Allscripts TouchWorks EHR Wiki
![Genetic & Lifestyle Calculator Reveals Which Younger Adults Are Most at Risk of Colorectal Cancer | NYU Langone News Genetic & Lifestyle Calculator Reveals Which Younger Adults Are Most at Risk of Colorectal Cancer | NYU Langone News](https://nyulangone.org/news/sites/default/files/styles/hero/public/2022-01/press-release-genetic-lifestyle-calculator-younger-adults-most-at-risk-colorectal-cancer.jpg?h=06ac0d8c&itok=CM2YjP24)
Genetic & Lifestyle Calculator Reveals Which Younger Adults Are Most at Risk of Colorectal Cancer | NYU Langone News
![Adding Breast Density and Benign Breast Disease into a Risk Assessment Tool increases Ability to Predict Risk of Breast Cancer | ASCO Connection Adding Breast Density and Benign Breast Disease into a Risk Assessment Tool increases Ability to Predict Risk of Breast Cancer | ASCO Connection](https://connection.asco.org/sites/asco_connection/files/styles/article_image/public/articles/images/JCO-BC-risk-01_747x556.png?itok=cPe2DoDV)
Adding Breast Density and Benign Breast Disease into a Risk Assessment Tool increases Ability to Predict Risk of Breast Cancer | ASCO Connection
![A calculator for prostate cancer risk 4 years after an initially negative screen: Findings from ERSPC Rotterdam, "Beyond the Abstract," by Xiaoye Zhu, MD and Monique J. Roobol, PhD, MSc A calculator for prostate cancer risk 4 years after an initially negative screen: Findings from ERSPC Rotterdam, "Beyond the Abstract," by Xiaoye Zhu, MD and Monique J. Roobol, PhD, MSc](https://www.urotoday.com/images/stories/Beyond_the_Abstract/bta_zhu_fig1c.jpg)